Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation

被引:399
作者
Giedraitis, V [1 ]
He, B [1 ]
Huang, WX [1 ]
Hillert, J [1 ]
机构
[1] Karolinska Inst, Huddinge Univ Hosp, Div Neurol, S-14186 Huddinge, Sweden
关键词
IL-18; mutation analysis; genetic susceptibility; multiple sclerosis;
D O I
10.1016/S0165-5728(00)00407-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-18 is a proinflammatory cytokine, which strongly induces IFN-gamma production. We have cloned the human IL-18 promoter and screened for possible polymorphisms. Three single nucleotide polymorphisms were detected in the promoter and two polymorphisms in the 5'-nontranslated region of the gene. Three combinations of these polymorphisms were observed in the Swedish population. All IL-18 promoter alleles were found to have clear promoter activity when inserted into a luciferase reporter vector. There were no significant differences in promoter activity between alleles without stimulation, but after stimulation with PMA/ionomicin one of the alleles had clearly lower activity than the other (P<0.01). Measurement of IL-18 and IFN-<gamma> production in 48 multiple sclerosis patients by RT-PCR showed slightly higher expression of IL-18 in individuals homozygous for the most frequent haplotype. Two IL-18 promoter polymorphisms were analyzed by sequence specific PCR in 208 multiple sclerosis patients and 139 healthy controls, however, no significant differences were found. In summary, our data indicate that common IL-18 promoter polymorphisms influence the expression of IL-18 and potentially also of IFN-gamma. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:146 / 152
页数:7
相关论文
共 24 条
[21]   Purification and characterization of the human interleukin-18 receptor [J].
Torigoe, K ;
Ushio, S ;
Okura, T ;
Kobayashi, S ;
Taniai, M ;
Kunikata, T ;
Murakami, T ;
Sanou, O ;
Kojima, H ;
Fujii, M ;
Ohta, T ;
Ikeda, M ;
Ikegami, H ;
Kurimoto, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) :25737-25742
[22]  
Ushio S, 1996, J IMMUNOL, V156, P4274
[23]  
Wildbaum G, 1998, J IMMUNOL, V161, P6368
[24]  
Yoshimoto T, 1998, J IMMUNOL, V161, P3400